(Q36392189)

13 August 2017

0 references

1 reference

title

Beneficial effects of extended-release doxazosin and doxazosin standard on sexual health (English)

1 reference

13 August 2017

1

Steven A Kaplan

1 reference

13 August 2017

Aldo F DE Rose

2

1 reference

13 August 2017

Roger S Kirby

series ordinal

3

1 reference

13 August 2017

Michael P O'leary

series ordinal

4

1 reference

13 August 2017

Kevin T McVary

series ordinal

5

1 reference

13 August 2017

publication date

1 March 2006

1 reference

13 August 2017

1 reference

13 August 2017

volume

97

1 reference

13 August 2017

issue

3

1 reference

13 August 2017

page(s)

559-566

1 reference

NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05959.X

The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05959.X

Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05959.X

Is the relation of systolic blood pressure to risk of cardiovascular disease continuous and graded, or are there critical values?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05959.X

Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05959.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05959.X

alpha1-adrenoceptor selectivity: the North American experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05959.X

Alpha 1-adrenoceptors in human prostate: characterization and binding characteristics of alpha 1-antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05959.X

Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05959.X

Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05959.X

Efficacy of extended-release doxazosin and doxazosin standard in patients with concomitant benign prostatic hyperplasia and sexual dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05959.X

Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05959.X

The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05959.X

Observational multicentric trial performed with doxazosin: evaluation of sexual effects on patients with diagnosed benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05959.X

Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05959.X

Combined oral therapy with sildenafil and doxazosin for the treatment of non-organic erectile dysfunction refractory to sildenafil monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05959.X

Recovery of erectile function after brief aggressive antihypertensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05959.X

Apoptotic impact of alpha1-blockers on prostate cancer growth: a myth or an inviting reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05959.X

Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05959.X

Role of alpha adrenergic receptors in erectile function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05959.X

10.1111/J.1464-410X.2005.05959.X

21 January 2018

Identifiers

DOI

1 reference

release_ayfih6xqyzhptjnaai2xee3g5i

13 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ayfih6xqyzhptjnaai2xee3g5i

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference